Clean Science & Technology Ltd

Clean Science & Technology Earnings Call Transcript: Key Takeaways

Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.

Clean Science & Technology Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.

Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY

Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.

Key figure

Net profit ₹55.7 Cr · +0.5% YoY

Clean Science & Technology Business Update

Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.

Clean Science & Technology Other Announcement

Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.

Clean Science & Technology Board Meeting Date

Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.